Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Economic Development topic
No spam. Unsubscribe anytime.
Board hears pitch from Campus Innovations Group for BioLife Science campus; agrees to discovery subcommittee
Summary
Campus Innovations Group presented a proposal to help the DeSoto Development Corporation advance a proposed BioLife Science campus. The board did not authorize the full proposal but agreed to a short discovery process with a three‑person subcommittee and to remove a proposed success fee and cap reimbursable expenses.
DeSoto Development Corporation board members heard a two‑hour presentation from Campus Innovations Group — a team of real estate, health care and university development veterans — about advancing a planned BioLife Science campus in DeSoto.
Consultants from Campus Innovations Group described prior industry work that includes partnerships with university medical centers and health systems, and outlined a proposed six‑month engagement to identify potential industry anchor tenants, refine a site plan and open industry and higher‑education conversations. Staff said the proposal in the board packet requested approximately $47,000 for the initial engagement and listed deliverables such as early introductions to potential tenants and funders and a preliminary list of recommended next steps.
Board members pressed presenters on sequencing, on how an anchor partner would be identified and how the DDC could retain control of a vision distinct from existing models in other parts of the region. Several board members stressed they want the project’s mission and vision to drive partner selection rather than preexisting relationships; others urged urgency to preserve momentum with university and industry contacts.
After extended questions and public discussion the board decided not to approve the full proposal at the meeting. Instead, members instructed staff to form a three‑person subcommittee to work directly with Campus Innovations Group on a short discovery engagement. The board removed the draft success‑fee language from the proposed contract and agreed to cap reimbursable out‑of‑pocket expenses for the discovery phase at $10,000. The subcommittee named in the meeting consists of Dr. GP (family practice physician/board member), Dr. Herndon (board member) and Akila Wallace (board director). Staff said the subcommittee will coordinate with presenters, define discovery deliverables, and return to the full board with a refined work plan and a special meeting to consider formal authorization.
Presenters emphasized that potential partners under discussion include research and workforce anchors such as UT Southwestern, Texas Health Resources and contract development/manufacturing organizations (CDMOs). Board members discussed the project’s long‑term aims to attract industry and create local jobs while improving community health and wellness. The board agreed the next materials should identify specific deliverables, partner roles, and benchmarks the council could use to evaluate proposals before authorizing larger expenditures.
